Holen Sie sich die Stockscreener-App
45.43
2.99%
1.32
Handel nachbörslich:
45.24
-0.19
-0.42%
Schlusskurs vom Vortag:
$44.11
Offen:
$43.51
24-Stunden-Volumen:
435.04K
Relative Volume:
0.41
Marktkapitalisierung:
$2.82B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-229.97M
KGV:
-10.51
EPS:
-4.3234
Netto-Cashflow:
$-136.51M
1W Leistung:
-1.54%
1M Leistung:
+22.78%
6M Leistung:
+136.06%
1J Leistung:
+979.10%
1-Tages-Spanne:
$43.03
$45.85
1-Wochen-Bereich:
$42.83
$47.84
52-Wochen-Spanne:
$2.8101
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
45.43 | 2.74B | 0 | -229.97M | -136.51M | -4.3234 |
VRTX
Vertex Pharmaceuticals Inc
|
430.14 | 108.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
731.77 | 78.05B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
775.03 | 48.74B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.11 | 41.16B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.16 | 33.17B | 5.36B | 287.73M | 924.18M | 2.5229 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Eingeleitet | Jefferies | Buy |
| 2025-08-14 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Kodiak Sciences stock is surging Friday: What's driving the action? - MSN
Diabetic Retinopathy Pipeline Set for Transformational Breakthroughs by 2026 with 55+ Therapies expanding Clinical Innovation from Kodiak Sciences, Regenxbio, Adverum Biotechnologies | DelveInsight - Barchart
Diabetic Retinopathy Pipeline Set for Transformational - openPR.com
BlackRock (KOD) holds 3.27M shares, a 5.3% stake in Kodiak Sciences (KOD) - Stock Titan
Kodiak Q4 loss wider than expected, pipeline development in focus - MSN
US stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage study - MSN
Kodiak climbs on late-stage trial win for diabetic retinopathy therapy - MSN
Kodiak Sciences Reports Positive Trial Results for Diabetic Retinopathy - HarianBasis.co
Kodiak Sciences Inc (KOD): What’s the Chance of Success for Zenkuda? - Insider Monkey
KOD Kodiak Sciences Inc reports narrow Q4 2025 EPS beat, shares drop 3.74 percent on weak investor sentiment.Viral Trade Signals - Xã Thanh Hà
[ARS] Kodiak Sciences Inc. SEC Filing - Stock Titan
Executive pay and 2026 director vote at Kodiak Sciences (NASDAQ: KOD) - Stock Titan
Is Kodiak Sciences (KOD) stock stronger than industry leaders (-1.28%) 2026-04-22Diversification - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Why Kodiak Sciences Stock Is On The Move - TipRanks
Kodiak Sciences Inc stock hits 52-week high at $46.69 By Investing.com - Investing.com Australia
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month HighWhat's Next? - MarketBeat
Kodiak Sciences Inc stock hits 52-week high at $46.69 - Investing.com
Kodiak Sciences (KOD) reports Q4 EPS of ($1.05) - MSN
Kodiak Sciences (NASDAQ:KOD) Stock Price Up 9.8%What's Next? - MarketBeat
Kodiak Sciences KOD Stock Soars On Phase 3 Win - timothysykes.com
Russell 2000 Rips To Record High — Here Are The Top Small Cap Gainers - Benzinga
Kodiak Sciences (NASDAQ: KOD) CFO exercises options, now holds 211,930 shares - Stock Titan
Kodiak Sciences (NASDAQ:KOD) Signals Behind Surge Points To Momentum - Kalkine Media
Kodiak Sciences Inc. (NASDAQ:KOD) Short Interest Up 39.8% in March - MarketBeat
Kodiak Sciences (KOD) Stock: Downtrend Signals? (Loses Ground) 2026-04-15Overvalued Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Kodiak Sciences Stock Price Drops 5.5% - National Today
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.5%Should You Sell? - MarketBeat
Kodiak Sciences shares jump on encouraging Phase 3 trial results - MSN
Kodiak Sciences (KOD) climbs 75% on stellar clinical results - MSN
Kodiak Sciences stock hits 52-week high at $45.73 By Investing.com - Investing.com Australia
Kodiak Sciences Stock Soars to New 52-Week High - National Today
Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week HighHere's What Happened - MarketBeat
Kodiak Sciences stock hits 52-week high at $45.73 - Investing.com
Breakouts Watch: Is Kodiak Sciences Inc stock a smart retirement pickWeekly Trend Report & Weekly High Return Forecasts - baoquankhu1.vn
KOD SEC FilingsKodiak Sciences Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Is Kodiak Sciences (KOD) Balancing Dilution Risk And Survival After Auditor's Going Concern Opinion? - Sahm
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) - Insider Monkey
Kodiak Sciences (KOD) price target increased by 56.62% to 56.71 - MSN
New Highs: How does Kodiak Sciences Inc compare to its peers2026 Trends & High Win Rate Trade Tips - baoquankhu1.vn
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):